Skip to main content Skip to main navigation menu Skip to site footer

Risk factor of progression of diabetic retinopathy after cataract surgery: a systematic review and meta-analysis

Abstract

Background: Several researchers have looked into the connection between cataract surgery and the progression of diabetic retinopathy (DR) in various studies. However, the element that places a patient at risk for the advancement of diabetic retinopathy following cataract surgery is still unknown. The primary goal of this meta-analysis is to conduct a comprehensive review of the existing research discussing the factors connected to the progression of diabetic retinopathy after cataract surgery.

Methods: A literature search in scientific literature databases, including Pubmed, ScienceDirect, and Cochrane Library, was conducted. Review Manager 5.4 (Cochrane Collaboration, Oxford, UK) measured and analyzed the risk factor's role in the progression of DR after cataract surgery. A significance value below 0.05 was determined statistically significant. 

Results: This review included 657 people from eight different studies. It discovered a significant impact of various parameters on the evolution of diabetic retinopathy after cataract surgery. Serum HbA1c levels (with a mean difference of 1.16; p<0.00), diabetes duration (with a mean difference of 1.89; p=0.02), age at cataract surgery (with a mean difference of -1.72; p=0.01), and insulin treatment (with an odds ratio of 3.74; p<0.00) all demonstrated significant associations with diabetic retinopathy progression after cataract surgery.

Conclusion: Our meta-analysis found that blood HbA1c level, diabetes duration, age at cataract surgery, and insulin treatment were all significant risk variables for postoperative DR progression.

References

  1. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis [Internet]. 2015;2(1):1–25. Available from: http://dx.doi.org/10.1186/s40662-015-0026-2
  2. Li L, Wan XH, Zhao GH. Meta-analysis of the risk of cataracts in type 2 diabetes. BMC Ophthalmol. 2014;14(1).
  3. Elanchezhian R, Palsamy P, Madson CJ, Mulhern ML, Lynch DW, Troia AM, et al. Low glucose under hypoxic conditions induces unfolded protein response and produces reactive oxygen species in lens epithelial cells. Cell Death Dis [Internet]. 2012;3(4):e301-9. Available from: http://dx.doi.org/10.1038/cddis.2012.40
  4. Thiagarajan R, Manikandan R. Antioxidants and cataract. Free Radic Res. 2013;47(5):337–45.
  5. Lee AYW, Chung SSM. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999;13(1):23–30.
  6. Rashid S, Young LH. Progression of Diabetic Retinopathy and Maculopathy After Phacoemulsification Surgery development compared with the general population. Cataract remains Progression of Diabetic Retinopathy After Phacoemulsification A systematic review of literature revea. 2010;50(1):155–66.
  7. Drinkwater JJ, Davis WA, Davis TME. A systematic review of risk factors for cataract in type 2 diabetes. Diabetes Metab Res Rev. 2019;35(1).
  8. Schalnus R, Ohrloff C. The blood-retina barrier and blood-aqueous humor barrier in type I diabetic patients without retinopathy. Determination of permeability using fluorophotometry and laser flare measurements. Klin Monbl Augenheilkd. 1993;202(4):281–7.
  9. Antonetti DA, Lieth E, Barber AJ, Gardner TW. Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol. 1999;14(4):240–8.
  10. Liu Y, Luo L, He M, Liu X. Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients. Eye. 2004;18(9):900–4.
  11. Jeng CJ, Hsieh YT, Yang CM, Yang CH, Lin CL, Wang IJ. Development of diabetic retinopathy after cataract surgery. PLoS One. 2018;13(8):1–12.
  12. Jaffe GJ, Burton TC, Kuhn E, Prescott A, Hartz A. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol. 1992;114(4):448–56.
  13. Kelkar A, Kelkar J, Mehta H, Amoaku W. Cataract surgery in diabetes mellitus: A systematic review. Indian J Ophthalmol. 2018 Oct;66(10):1401–10.
  14. Tham YC, Liu L, Rim TH, Zhang L, Majithia S, Chee ML, et al. Association of Cataract Surgery With Risk of Diabetic Retinopathy Among Asian Participants in the Singapore Epidemiology of Eye Diseases Study. JAMA Netw open. 2020;3(6):e208035.
  15. Squirrell D, Bhola R, Bush J, Winder S, Talbot JF, Hykin PG. Prospective, case-controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Evidence-Based Eye Care. 2003;4(1):28–9.
  16. Dowler JGF, Sehmi KS, Hykin PG, Hamilton AMP. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology. 1999;106(4):663–8.
  17. Hong T, Mitchell P, de Loryn T, Rochtchina E, Cugati S, Wang JJ. Development and Progression of Diabetic Retinopathy 12 Months after Phacoemulsification Cataract Surgery. Ophthalmology [Internet]. 2009;116(8):1510–4. Available from: http://dx.doi.org/10.1016/j.ophtha.2009.03.003
  18. Romero-Aroca P, Fernández-Ballart J, Almena-Garcia M, Méndez-Marín I, Salvat-Serra M, Buil-Calvo JA. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: Prospective study. J Cataract Refract Surg. 2006;32(9):1438–44.
  19. Hauser D, Katz H, Pokroy R, Bukelman A, Shechtman E, Pollack A. Occurrence and progression of diabetic retinopathy after phacoemulsification cataract surgery. J Cataract Refract Surg. 2004;30(2):428–32.
  20. Liao S Bin, Ku WC. Progression of Diabetic Retinopathy after Phacoemulsification in Diabetic Patients: A Three-Year Analysis. Chang Gung Med J. 2003;26(11):829–34.
  21. Flesner P, Sander B, Henning V, Parving HH, Dornonville De La Cour M, Lund-Andersen H. Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications. Acta Ophthalmol Scand. 2002;80(1):19–24.
  22. Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol. 1996;80(9):789–93.
  23. Pollack A, Dotan S, Moshe O. Progression of diabetic retinopathy after cataract extraction. Br J Ophthalmol. 1991;75(1):547–51.
  24. Yang J, Cai L, Sun Z, Ye H, Fan Q, Zhang K, et al. Risk factors for and diagnosis of pseudophakic cystoid macular edema after cataract surgery in diabetic patients. J Cataract Refract Surg [Internet]. 2017;43(2):207–14. Available from: http://dx.doi.org/10.1016/j.jcrs.2016.11.047
  25. Vantarakis A, Li Y, Liu JJ, Qi P, Rapoport Y, Wayman LL, et al. Cataract surgery in diabetes mellitus: A systematic review. BMC Ophthalmol [Internet]. 2017;17(1):1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28331284%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5354527%5Cnhttp://bmcpsychiatry.biomedcentral.com/articles/10.1186/1471-244X-11-49%5Cnhttp://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886
  26. Ostri C, Lund-Andersen H, Sander B, La Cour M. Phacoemulsification cataract surgery in a large cohort of diabetes patients: Visual acuity outcomes and prognostic factors. J Cataract Refract Surg [Internet]. 2011;37(11):2006–12. Available from: http://dx.doi.org/10.1016/j.jcrs.2011.05.030
  27. Hashim Z, Zarina S. Osmotic stress induced oxidative damage: Possible mechanism of cataract formation in diabetes. J Diabetes Complications [Internet]. 2012;26(4):275–9. Available from: http://dx.doi.org/10.1016/j.jdiacomp.2012.04.005
  28. Zhang P, Xing K, Randazzo J, Blessing K, Lou MF, Kador PF. Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation. Exp Eye Res [Internet]. 2012;101:36–43. Available from: http://dx.doi.org/10.1016/j.exer.2012.05.007
  29. Mittra RA, Borrillo JL, Dev S, Mieler WF, Koenig SB. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol. 2000;118(7):912–7.
  30. Bu Y, Shih KC, Tong L. The ocular surface and diabetes, the other 21st Century epidemic. Exp Eye Res [Internet]. 2022;220(April):109099. Available from: https://doi.org/10.1016/j.exer.2022.109099
  31. Kumar CM, Seet E, Eke T, Joshi GP. Hypertension and cataract surgery under loco-regional anaesthesia: Not to be ignored? Br J Anaesth. 2017;119(5):855–9.
  32. Magri MP de F, de Espíndola RF, de Santhiago MR, Mercadante EF, Kara Júnior N. Cancellation of cataract surgery in a public hospital. Arq Bras Oftalmol. 2012;75(5):333–6.
  33. Hartle A, McCormack T, Carlisle J, Anderson S, Pichel A, Beckett N, et al. The measurement of adult blood pressure and management of hypertension before elective surgery: Joint Guidelines from the Association of Anaesthetists of Great Britain and Ireland and the British Hypertension Society. Anaesthesia. 2016;71(3):326–37.
  34. Lundqvist B, Mönestam E. Gender-related differences in cataract surgery outcome: A 5-year follow-up. Acta Ophthalmol. 2008;86(5):543–8.

How to Cite

Saraswati, P. P. T., Nyoman Yuni Suryani Dharmaputri P, Suryathi, N. M. A. ., & Andayani, A. . (2024). Risk factor of progression of diabetic retinopathy after cataract surgery: a systematic review and meta-analysis. Intisari Sains Medis, 15(1), 414–419. https://doi.org/10.15562/ism.v15i1.1997

HTML
0

Total
0

Share

Search Panel

Putu Putri Titamia Saraswati
Google Scholar
Pubmed
ISM Journal


Nyoman Yuni Suryani Dharmaputri P
Google Scholar
Pubmed
ISM Journal


Ni Made Ari Suryathi
Google Scholar
Pubmed
ISM Journal


Ari Andayani
Google Scholar
Pubmed
ISM Journal